This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Back to previous page

Open Book: Alert for prescribing error – dabigatran and enoxaparin (July 2017)

15th December, 2021

This report alerts providers to adverse event cases reported to the Commission’s Adverse Events Learning Programme.

It highlights the risks when prescribers are unaware of the requirements for prescribing dabigatran or switching between enoxaparin (Clexane) and dabigatran (Pradaxa).

The requirements are different to when starting warfarin or switching between warfarin and enoxaparin.


Relevant pages

Last updated: 15th December, 2021